Does New Opioid Law Require Clinical Laboratories to Change How They Pay Sales Employees?

Recently enacted EKRA law prohibits payment activities that were legal under the previous Anti-Kickback Statute, confusing clinical laboratories and legal experts alike There is a relatively new law on the books that impacts clinical laboratories, and lab leaders tasked with ensuring compliance with federal statutes need to fully understand it because getting it wrong could have dire consequences. The Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for...

Reappearance of Victorian Era Diseases Highlight Importance of Clinical Laboratory Vigilance

As admissions for scarlet fever, whooping cough, scurvy, and other “Dickensian Era” diseases rise, medical laboratories must continue to consider uncommon causes when performing tests and providing data to physicians developing treatment plans Resurgence in once-rare diseases and conditions in both the United Kingdom and the United States highlight the importance of recognizing the unlikely and unexpected when ordering and performing medical laboratory testing. While a large portion of tests...

PAMA Price Reporting Update: Insights to Help Prepare to Meet the Requirement

Prior (2018) price reporting cycle offers lessons that can help clinical laboratory benefit administrators and personnel take an informed approach to meeting the requirements of the Protecting Access to Medicare Act of 2014 (PAMA) With the PAMA Private Payor Price Reporting period under way, some clinical laboratories may be grappling with questions about the new requirements. Under PAMA, applicable labs must report private payer data on selected Clinical Diagnostic Laboratory Tests (CDLTs) to...

Medicare-for-All Bill Has Little Chance of Passage in Congress, Even as Universal Healthcare Debate Gains Momentum Among Democratic Presidential Hopefuls

Massive government takeover of healthcare would create single-payer healthcare system, doing away with Medicare Advantage and individual choice All clinical laboratories and anatomic pathology groups have a strong interest in how any reform of US healthcare at the federal level might be accomplished. In that spirit, Dark Daily is providing a quick overview of the Medicare for All Act of 2019 (HR 1384). The name is misleading. The bill would actually end Medicare and all private health...

Mt. Sinai Hospital and Cactus Design Studio Create 8-Station Clinical/Research Laboratory to Assess Health and Prevent Disease

Lab100 is designed to be easily upgraded with the latest medical laboratory technologies for tracking patients’ health metrics and risk for chronic diseases Mount Sinai Hospital and Cactus, a New York City-based design studio, are creating a hybrid clinical laboratory/research lab that uses the latest diagnostic technologies to assess peoples’ health, provide them with an overview of their current condition, and suggest lifestyle changes to prevent future diseases. Though still under...

Researchers at Johns Hopkins University Use AI and Human Gut Bacteria to Predict Age of Microbiome Hosts

Clinical laboratories could soon have new tests for determining how fast a patient’s digestive system is aging as part of a precision medicine treatment protocol When it comes to assessing human age and longevity, much research has focused on telomeres in recent years. Now clinical laboratory managers and pathologists will be interested to learn that provocative new research demonstrates that the human microbiome may also contain useful information about aging. Microbes that can be diagnostic...